News & Perspective

Sep 09, 2003

Sep 09, 2003

NIAID to test immunoglobulin for West Nile encephalitis

(CIDRAP News) – The National Institute of Allergy and Infectious Disease (NIAID) yesterday announced a clinical trial to assess whether a new immunoglobulin product can alleviate or prevent encephalitis in patients infected with West Nile virus (WNV).

Sort Results By:

 Sort Results By:

Narrow results by:

Newsletter Sign-up

Get CIDRAP news and other free newsletters.

Sign up now»


Unrestricted financial support provided by

Bentson Foundation 3MAccelerate DiagnosticsGilead 
Grant support for ASP provided by


  Become an underwriter»